GridAI Technologies (GRDX) Preferred Shares (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Preferred Shares came in at $4.0 in Q4 2025, down 99.95% on a QoQ basis from $7700.0 in Q2 2021.

GridAI Technologies (GRDX) Preferred Shares (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 3 years of Preferred Shares data on file, last reported at $4.0 in Q4 2025.

Quarterly Preferred Shares changed N/A year-over-year to $4.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 (changed N/A YoY) and the FY2025 annual result came in at $4.0, changed N/A from the prior year.
Preferred Shares fell to $4.0 in Q4 2025, from $7700.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $7700.0 in Q2 2021 to a low of $4.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.79 Bn	131.94 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.74 Bn	78.74 Bn	3.93 Bn	-
3	Argenx Se	65.48 Bn	60.29 Bn	1.37 Bn	-
4	Moderna	59.32 Bn	54.18 Bn	52.00 Mn	-
5	BeOne Medicines	42.08 Bn	36.98 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.81 Bn	28.50 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.56 Bn	26.40 Bn	358.27 Mn	-
9	Royalty Pharma	27.29 Bn	26.45 Bn	-	-
10	GridAI Technologies	6.06 Mn	6.06 Mn	-	4.00

Download Data